JAZZ Jazz Pharmaceuticals plc: institutional ownership and insider trading
700 funds reported holding $16.8B of Jazz Pharmaceuticals plc in their latest 13F filings; in Q2 2026 funds net sold $185M, with 130 new positions and 56 funds selling out; over the last 12 months insiders bought $0 and sold $69.8M on the open market.
Famous investors holding JAZZ
- Tweedy, Browne (Tweedy, Browne Company): $14.5M, 1.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $135M, 0.2% of the portfolio
- Izzy Englander (Millennium Management): $184M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $96.4M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $262M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $21.0M, 0.0% of the portfolio
Largest institutional holders of JAZZ
- BlackRock, Inc. (BLK) — $1.44B
- FMR LLC — $1.11B
- VANGUARD GROUP INC — $1.01B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $732M
- VANGUARD CAPITAL MANAGEMENT LLC — $658M
- Capital World Investors — $650M
- LSV ASSET MANAGEMENT — $548M
- FRANKLIN RESOURCES INC (BEN) — $492M
- STATE STREET CORP (STT, STT-PG) — $482M
- DIMENSIONAL FUND ADVISORS LP — $413M
Recent JAZZ insider trades
- Oct 6, 2026: Gala Renee D sold 2,000 shares ($473K)
- Oct 1, 2026: Cozadd Bruce C sold 6,000 shares ($1.38M)
- Sep 10, 2026: Patil Neena M sold 1,200 shares ($289K)
- Sep 8, 2026: Gala Renee D sold 2,000 shares ($486K)
5%+ owners
- FMR LLC: 7.4% (Schedule 13G, filed Aug 6, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Apr 30, 2026)